American Heart Association: Experimental antiplatelet compound for acute stroke shows promise

April 2019.  An experimental antiplatelet compound inhibited clot formation without increasing bleeding, a common and potentially dangerous side effect of current anticlotting therapies, according to new phase I research in Arteriosclerosis, Thrombosis

Read full article

Initial Public Offering on Euronext Growth® Paris • See details